Erratum: The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet (Cell (2018) 173(7) (1728–1741.e13) (S0092867418305208) (10.1016/j.cell.2018.04.027));The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet

Cell

Volumn 173, Issue 7, 2018, Pages 1728-1741.e13

  Olson, Christine A ^a   Vuong, Helen E ^a   Yano, Jessica M ^a   Liang, Qingxing Y ^a   Nusbaum, David J ^a   Hsiao, Elaine Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

6 Hz seizures; Akkermansia; epilepsy; gamma glutamyl transpeptidase; GGsTop; Kcna1; ketogenic diet; microbiome; microbiota; Parabacteroides

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; AMPICILLIN; ESSENTIAL AMINO ACID; GAMMA GLUTAMYLTRANSFERASE; GLUTAMIC ACID; LEUCINE; LYSINE; METRONIDAZOLE; NEOMYCIN; POTASSIUM CHANNEL KV1.1; TRYPTOPHAN; TYROSINE; VANCOMYCIN; ANTIINFECTIVE AGENT; KCNA1 PROTEIN, MOUSE; RNA 16S;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; BACTEROIDES; CELL SURFACE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DRUG RESISTANT EPILEPSY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GNOTOBIOTICS; HUMAN; INTESTINE FLORA; KETOGENIC DIET; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; PARABACTEROIDES; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE; ANIMAL; C3H MOUSE; DEFICIENCY; DIET THERAPY; DISEASE MODEL; DRUG EFFECT; FECES; GENETICS; HIPPOCAMPUS; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; KNOCKOUT MOUSE; METABOLISM; METABOLOME; MICROBIOLOGY; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; SEIZURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEROIDES; DIET, KETOGENIC; DISEASE MODELS, ANIMAL; FECES; GAMMA-AMINOBUTYRIC ACID; GAMMA-GLUTAMYLTRANSFERASE; GASTROINTESTINAL MICROBIOME; GLUTAMIC ACID; HIPPOCAMPUS; INTESTINAL MUCOSA; KV1.1 POTASSIUM CHANNEL; METABOLOME; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; PRINCIPAL COMPONENT ANALYSIS; RNA, RIBOSOMAL, 16S; SEIZURES;

EID: 85046857479     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2018.06.051     Document Type: Erratum

References (53)

1. Baraban, S.C., Southwell, D.G., Estrada, R.C., Jones, D.L., Sebe, J.Y., Alfaro-Cervello, C., García-Verdugo, J.M., Rubenstein, J.L., Alvarez-Buylla, A., Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc. Natl. Acad. Sci. USA 106 (2009), 15472–15477.
2. Barton, M.E., Klein, B.D., Wolf, H.H., White, H.S., Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res. 47 (2001), 217–227.
3. Beloosesky, Y., Grosman, B., Marmelstein, V., Grinblat, J., Convulsions induced by metronidazole treatment for Clostridium difficile-associated disease in chronic renal failure. Am. J. Med. Sci. 319 (2000), 338–339.
4. Bough, K.J., Rho, J.M., Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48 (2007), 43–58.
5. Buffington, S.A., Di Prisco, G.V., Auchtung, T.A., Ajami, N.J., Petrosino, J.F., Costa-Mattioli, M., Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165 (2016), 1762–1775.
6. Calderón, N., Betancourt, L., Hernández, L., Rada, P., A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study. Neurosci. Lett. 642 (2017), 158–162.
7. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Peña, A.G., Goodrich, J.K., Gordon, J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
8. Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Lozupone, C.A., Turnbaugh, P.J., Fierer, N., Knight, R., Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2011), 4516–4522.
9. Castellano, I., Merlino, A., γ-Glutamyltranspeptidases: sequence, structure, biochemical properties, and biotechnological applications. Cell. Mol. Life Sci. 69 (2012), 3381–3394.
10. Cooper, A.J., Jeitner, T.M., Central role of glutamate metabolism in the maintenance of nitrogen homeostasis in normal and hyperammonemic brain. Biomolecules, 6, 2016, E16.
11. Crawford, P.A., Crowley, J.R., Sambandam, N., Muegge, B.D., Costello, E.K., Hamady, M., Knight, R., Gordon, J.I., Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc. Natl. Acad. Sci. USA 106 (2009), 11276–11281.
12. Dahlin, M., Elfving, A., Ungerstedt, U., Amark, P., The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 64 (2005), 115–125.
13. Dao, M.C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O., Kayser, B.D., Levenez, F., Chilloux, J., Hoyles, L., et al., MICRO-Obes Consortium. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65 (2016), 426–436.
14. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
15. Derrien, M., Collado, M.C., Ben-Amor, K., Salminen, S., de Vos, W.M., The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 74 (2008), 1646–1648.
16. Duncan, S.H., Lobley, G.E., Holtrop, G., Ince, J., Johnstone, A.M., Louis, P., Flint, H.J., Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 32 (2008), 1720–1724.
17. Dutton, S.B., Sawyer, N.T., Kalume, F., Jumbo-Lucioni, P., Borges, K., Catterall, W.A., Escayg, A., Protective effect of the ketogenic diet in Scn1a mutant mice. Epilepsia 52 (2011), 2050–2056.
18. Eraković V., Župan, G., Varljen, J., Laginja, J., Simonić A., Altered activities of rat brain metabolic enzymes in electroconvulsive shock-induced seizures. Epilepsia 42 (2001), 181–189.
19. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110 (2013), 9066–9071.
20. Ewen, L.M., Griffiths, J., -Glutamyl transpeptidase: elevated activities in certain neurologic diseases. Am. J. Clin. Pathol. 59 (1973), 2–9.
21. Fenoglio-Simeone, K.A., Wilke, J.C., Milligan, H.L., Allen, C.N., Rho, J.M., Maganti, R.K., Ketogenic diet treatment abolishes seizure periodicity and improves diurnal rhythmicity in epileptic Kcna1-null mice. Epilepsia 50 (2009), 2027–2034.
22. Flynn, J.M., Niccum, D., Dunitz, J.M., Hunter, R.C., Evidence and role for bacterial mucin degradation in cystic fibrosis airway disease. PLoS Pathog., 12, 2016, e1005846.
23. Freeman, J.M., Kossoff, E.H., Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. Adv. Pediatr. 57 (2010), 315–329.
24. Frost, G., Sleeth, M.L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., Hankir, M., Zhang, S., et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun., 5, 2014, 3611.
25. Hartman, A.L., Zheng, X., Bergbower, E., Kennedy, M., Hardwick, J.M., Seizure tests distinguish intermittent fasting from the ketogenic diet. Epilepsia 51 (2010), 1395–1402.
26. Hornik, C.P., Benjamin, D.K. Jr., Smith, P.B., Pencina, M.J., Tremoulet, A.H., Capparelli, E.V., Ericson, J.E., Clark, R.H., Cohen-Wolkowiez, M., Best Pharmaceuticals for Children Act—Pediatric Trials Network. Electronic health records and pharmacokinetic modeling to assess the relationship between ampicillin exposure and seizure risk in neonates. J. Pediatr. 178 (2016), 125–129.
27. Janik, R., Thomason, L.A.M., Stanisz, A.M., Forsythe, P., Bienenstock, J., Stanisz, G.J., Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate. Neuroimage 125 (2016), 988–995.
28. Kimball, A.W., Burnett, W.T. Jr., Doherty, D.G., Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice. Radiat. Res. 7 (1957), 1–12.
29. Klein, M.S., Newell, C., Bomhof, M.R., Reimer, R.A., Hittel, D.S., Rho, J.M., Vogel, H.J., Shearer, J., Metabolomic modeling to monitor host responsiveness to gut microbiota manipulation in the BTBR(T+tf/j) mouse. J. Proteome Res. 15 (2016), 1143–1150.
30. Koeth, R.A., Wang, Z., Levison, B.S., Buffa, J.A., Org, E., Sheehy, B.T., Britt, E.B., Fu, X., Wu, Y., Li, L., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19 (2013), 576–585.
31. Kwan, P., Brodie, M.J., Early identification of refractory epilepsy. N. Engl. J. Med. 342 (2000), 314–319.
32. Langille, M.G.I., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., Clemente, J.C., Burkepile, D.E., Vega Thurber, R.L., Knight, R., et al. (2013). Nature Biotechnology 31, 814–821.
33. Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., Schleifer, K.H., Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142 (1996), 1097–1106.
34. Newell, C., Bomhof, M.R., Reimer, R.A., Hittel, D.S., Rho, J.M., Shearer, J., Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol. Autism, 7, 2016, 37.
35. Reikvam, D.H., Erofeev, A., Sandvik, A., Grcic, V., Jahnsen, F.L., Gaustad, P., McCoy, K.D., Macpherson, A.J., Meza-Zepeda, L.A., Johansen, F.E., Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS ONE, 6, 2011, e17996.
36. Remely, M., Hippe, B., Geretschlaeger, I., Stegmayer, S., Hoefinger, I., Haslberger, A., Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wien. Klin. Wochenschr. 127 (2015), 394–398.
37. Rogawski, M.A., Löscher, W., Rho, J.M., Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb. Perspect. Med., 6, 2016, a022780.
38. Samala, R., Willis, S., Borges, K., Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res. 81 (2008), 119–127.
39. Sariego-Jamardo, A., García-Cazorla, A., Artuch, R., Castejón, E., García-Arenas, D., Molero-Luis, M., Ormazábal, A., Sanmartí F.X., Efficacy of the ketogenic diet for the treatment of refractory childhood epilepsy: cerebrospinal fluid neurotransmitters and amino acid levels. Pediatr. Neurol. 53 (2015), 422–426.
40. Sato, S.M., Woolley, C.S., Acute inhibition of neurosteroid estrogen synthesis suppresses status epilepticus in an animal model. eLife, 5, 2016, e12917.
41. Scheffer, H., Brunt, E.R., Mol, G.J., van der Vlies, P., Stulp, R.P., Verlind, E., Mantel, G., Averyanov, Y.N., Hofstra, R.M., Buys, C.H., Three novel KCNA1 mutations in episodic ataxia type I families. Hum. Genet. 102 (1998), 464–466.
42. Semple, B.D., Blomgren, K., Gimlin, K., Ferriero, D.M., Noble-Haeusslein, L.J., Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 106-107 (2013), 1–16.
43. Simeone, K.A., Matthews, S.A., Rho, J.M., Simeone, T.A., Ketogenic diet treatment increases longevity in Kcna1-null mice, a model of sudden unexpected death in epilepsy. Epilepsia 57 (2016), e178–e182.
44. Smith, Q.R., Transport of glutamate and other amino acids at the blood-brain barrier. J. Nutr. 130:4S Suppl (2000), 1016S–1022S.
45. Smith, M.I., Yatsunenko, T., Manary, M.J., Trehan, I., Mkakosya, R., Cheng, J., Kau, A.L., Rich, S.S., Concannon, P., Mychaleckyj, J.C., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339 (2013), 548–554.
46. Sonnenburg, J.L., Bäckhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
47. Stafstrom, C.E., Rho, J.M., The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front. Pharmacol., 3, 2012, 59.
48. Sutter, R., Rüegg, S., Tschudin-Sutter, S., Seizures as adverse events of antibiotic drugs: A systematic review. Neurology 85 (2015), 1332–1341.
49. van der Stel, A.X., van Mourik, A., Łaniewski, P., van Putten, J.P., Jagusztyn-Krynicka, E.K., Wösten, M.M., The Campylobacter jejuni RacRS two-component system activates the glutamate synthesis by directly upregulating γ-glutamyltranspeptidase (GGT). Front. Microbiol., 6, 2015, 567.
50. Vuong, H.E., Yano, J.M., Fung, T.C., Hsiao, E.Y., The microbiome and host behavior. Annu. Rev. Neurosci. 40 (2017), 21–49.
51. Wang, Z.J., Bergqvist, C., Hunter, J.V., Jin, D., Wang, D.J., Wehrli, S., Zimmerman, R.A., In vivo measurement of brain metabolites using two-dimensional double-quantum MR spectroscopy–exploration of GABA levels in a ketogenic diet. Magn. Reson. Med. 49 (2003), 615–619.
52. Yudkoff, M., Daikhin, Y., Nissim, I., Lazarow, A., Nissim, I., Ketogenic diet, amino acid metabolism, and seizure control. J. Neurosci. Res. 66 (2001), 931–940.
53. Zuberi, S.M., Eunson, L.H., Spauschus, A., De Silva, R., Tolmie, J., Wood, N.W., McWilliam, R.C., Stephenson, J.B., Kullmann, D.M., Hanna, M.G., A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122 (1999), 817–825.